Clovis Oncology (CLVS): SEC Form SC 13G/A filed
Stocks in this Quantisnow insightHealth Care
Keep researching CLVS
- What is Schedule 13G?A short-form SEC disclosure for investors who own more than 5% of a company's voting stock but hold it passively, without intent to influence control.
- Schedule 13D vs 13GSchedule 13D vs 13G explained: who must file when crossing 5% ownership, the 2024 deadlines, how activists differ from passive holders, and what Item 4 reveals.
Quantisnow market dataNASDAQ
CLVS
Clovis Oncology Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2011
Get push alerts for CLVS
Full CLVS profile on Quantisnow Follow CLVS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time